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Abstract 
Humans and other animals are exposed to a wide array of man-made toxicants, 
many of which act as endocrine disruptors that exhibit differential effects across the 
lifespan.  Although adult exposure effects in humans are known for some compounds, the 
impact of developmental exposure to endocrine disrupting chemicals (EDCs) is more 
difficult to ascertain.  Animal studies have revealed that exposure to EDCs prior to puberty 
can lead to adult reproductive disease and dysfunction. Specifically, in adult female mice 
with an early life exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), we demonstrated 
a transgenerational occurrence of several reproductive diseases that have been linked to 
endometriosis in women. Herein, we review the evidence for TCDD-associated 
development of adult reproductive disease as well as known epigenetic alterations 
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models which, combined with our established murine model, are expected to further 
enhance our ability to examine alterations in gene-environment interactions that lead to 
heritable disease. 
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Abstract 
Humans and other animals are exposed to a wide array of man-made toxicants, many of 
which act as endocrine disruptors that exhibit differential effects across the lifespan.  Although 
adult exposure effects in humans are known for some compounds, the impact of developmental 
exposure to endocrine disrupting chemicals (EDCs) is more difficult to ascertain.  Animal studies 
have revealed that exposure to EDCs prior to puberty can lead to adult reproductive disease and 
dysfunction. Specifically, in adult female mice with an early life exposure to 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), we demonstrated a transgenerational occurrence of several 
reproductive diseases that have been linked to endometriosis in women. Herein, we review the 
evidence for TCDD-associated development of adult reproductive disease as well as known 
epigenetic alterations associated with TCDD and/or endometriosis. We will also introduce new 
³2UJDQ-on-&KLS´ PRGHOV ZKLFK FRPELQHG ZLWK RXU HVWDblished murine model, are expected to 
further enhance our ability to examine alterations in gene-environment interactions that lead to 
heritable disease. 
Key Words:  TCDD, transgenerational, endometriosis, adenomyosis, preterm birth, epigenetics 
  
1. Introduction 
Endometriosis, the presence of endometrial glands and stroma growing outside the uterus, 
is a common and debilitating gynecologic disease of uncertain etiology [1].  Women with this 
disease frequently suffer from chronic pelvic pain, subfertility and, as recently noted, an enhanced 
risk of spontaneous preterm birth (sPTB) [1, 2].  Common co-morbidities among these patients 
include adenomyosis, adhesive disease and inflammatory diseases such as interstitial cystitis and 
inflammatory bowel disease [3-5].  However, understanding the natural history of endometriosis, as 
well as the myriad of equally poorly understood diseases that often accompany it, has proven to be 
elusive.  Multiple theories for development of endometriosis have been proffered, including ectopic 
implantation of retrograde menstruation, coelomic metaplasia and activation of embryonic cell rests 
(reviewed in [6]).  Endometriosis is also known to have a familial component and several genetic 
polymorphisms have been associated with occurrence of this disease [1, 7], but as yet, no gene 
has been definitively linked to the development of this complex disease [8]. 
Following the occurrence of severe, life-threatening endometriosis in a colony of rhesus 
monkeys previously exposed to the common, widespread environmental toxicant and endocrine 
disruptor TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) [9], numerous human and animal studies 
examining the relationship between this endocrine disrupting chemical (EDC) and endometriosis 
ensued.  Although animal studies [10-14] and in vitro analysis of human tissues [15, 16] supported 
a potential role of this toxicant in the development of endometriosis, several epidemiology studies 
failed to link adult body burden to the presence of disease (reviewed by [17-19]).  However, a 
growing body of evidence suggests that numerous adult diseases may have their origin within the 
environment of early pregnancy (reviewed by [20]). TCDD and other dioxins readily cross the 
placenta; thus, fetal exposure to these EDCs is likely the norm rather than the exception [21].  For 
these reasons, our research group has explored the potential role of in utero TCDD exposure on 
the subsequent development of adult reproductive tract disease, with a specific focus on the 
uterine phenotype(s) associated with endometriosis.   
Unlike humans and other primates, mice do not menstruate and thus, do not naturally 
develop ectopic lesions which are the pathological hallmark of endometriosis.  Nevertheless, our 
studies revealed that the eutopic uterine phenotype of mice with a developmental exposure history 
was markedly similar to that of women with endometriosis.  Specifically, TCDD exposed mice, like 
women with endometriosis, exhibit reduced endometrial progesterone receptor (PR) expression as 
well as altered expression of transforming growth factor-E2 [22], proteins which are critical for 
successful establishment and maintenance of pregnancy.  Additional studies utilizing this murine 
model, detailed below, indicated that reproductive tract disease associated with TCDD exposure is 
not limited to the endometriosis phenotype nor to only the first generation of offspring following 
maternal exposure.  Furthermore, our studies and those from other groups provide evidence that 
reproductive tract disease and dysfunction may be a consequence of epigenetic alterations 
induced by a previous exposure to bioactive chemical contaminants [10, 12, 23-26].  Significantly, 
experimental animal studies indicate that epigenetic alterations occurring in either the male or 
female germline are capable of negatively affecting reproductive health for multiple generations 
[27-29] and underscore the urgent need to better understand the pathogenic mechanisms and 
functional impact of toxicant-mediated cellular changes in humans so that appropriate therapeutic 
intervention and/or lifestyle-related preventive strategies can be developed.  
Herein, we will review our studies in mice with a history of developmental TCDD exposure, 
detailing the observed adult reproductive effects that may be translatable to humans.  We will also 
review relevant in vivo observations in women as well as in vitro cell studies, which link TCDD and 
related EDCs to adult reproductive dysfunction, with a specific focus on the role that inflammation 
plays in the pathogenesis of endometriosis and related disorders. 
2. Environmental Endocrine Disruptors    
Thousands of chemicals are released into our environment each year, but current 
regulations do not require prospective risk assessment of these multiple, potentially interactive 
chemicals on human health [30].  Nevertheless, it has been demonstrated that some of these 
chemicals can act as disruptors of endocrine and immune system development, potentially 
compromising not only adult reproductive health but also promoting cancer, obesity and metabolic 
syndrome [20, 31-34].  The endometrium, which undergoes cyclical patterns of endocrine and 
immune signaling that regulate its growth and function during the reproductive years, is particularly 
sensitive to these endocrine disrupting chemicals (EDCs). In order to begin to assess the impact of 
early life EDC exposure on this tissue, we have utilized TCDD as a prototypical endocrine/immune 
disrupting toxicant for our studies due to the well-established toxicity and high affinity binding 
characteristics of this compound to the aryl hydrocarbon receptor (AhR).  The AhR, an orphan 
nuclear receptor, is abundantly expressed within human and murine reproductive tissues [35, 36].  
Significantly, male and female Ahr knockout mice exhibit reduced fertility and pregnancy loss, 
implicating the presence of endogenous ligands for this receptor in normal reproductive function 
[37].  Indeed, the AhR gene is highly conserved across all mammalian species examined and is 
considered to be important for normal embryonic development [38]. Although the primary 
physiologic ligand remains currently unclear, a number of endogenous compounds (indirubin, 
bilirubin, lipoxin A4, prostaglandin G and several dietary carotenoids) have been found to bind the 
AhR and act as weak agonists [39-42] or antagonists (7-ketocholesterol, resveratrol and 
chrysoeriol) [43-45].  Exogenous AhR agonists of environmental concern include TCDD and 
benz(a)pyrene, products of industrial processes and cigarette smoke which are known disruptors 
of male and female reproductive function in multiple species [46-48]. Furthermore, numerous 
experimental studies reveal sex-specific effects of developmental TCDD exposure with regard to 
adult behavior, metabolism and endocrine action [49-52], which may be related to variations in 
AhR expression patterns [49]. 7KXV D SHUVRQ¶V age, diet, smoking status and gender can each 
influence the impact of exposure to a toxicant such as TCDD, further complicating human 
epidemiology studies related to reproductive health. 
 
2.1. TCDD and related compounds 
TCDD belongs to the dioxin/dioxin-like family of environmental contaminants which includes 
polychlorinated dibenzodioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), co-planar 
polychlorinated biphenyls (PCBs) and mono-ortho-substituted PCBs [2, 3]. Among the numerous 
environmental toxicants which comprise the dioxin/dioxin-like family, TCDD is considered the most 
toxic and has been shown to disrupt steroid receptor levels as well as steroid metabolism and 
transport [36, 53-55]. The known biological effects of TCDD are numerous, but the consequences 
of chronic low-dose exposure to this toxicant on mechanistic pathways within the reproductive 
system remain poorly understood.  The cellular effects of TCDD exposure are primarily mediated 
through high affinity binding to the AhR, which subsequently forms an activated heterodimeric 
complex with the structurally related Aryl Hydrocarbon Nuclear Transport protein (ARNT)[56]. The 
activated AhR-ARNT complex binds to specific DNA enhancer sequences known as dioxin 
response elements (DREs) which subsequently affects the expression of specific genes, including 
multiple steroid receptors. TCDD also stimulates expression of CYP1A1, a drug metabolizing liver 
enzyme, but TCDD is a chemically stable toxicant that is not readily metabolized by biological 
pathways in most species [57, 58]. 
 TCDD is introduced to our environment largely as an unwanted by-product of 
manufacturing processes, incineration and burning of fossil fuels, although volcanic eruptions and 
forest fires also contribute to the overall environmental burden of dioxins.  Among human and 
animal populations, ingestion of contaminated food is the primary source of dioxin exposure [59-
62]. Unfortunately, as noted above, these compounds are resistant to either chemical or biological 
degradation and thus they exhibit a significant degree of bioaccumulation and environmental 
persistence [63].  Nevertheless, stricter emission standards and reduced pollution in first world 
countries has led to a significant decline in TCDD exposure in residents of the United States, 
Canada, Germany and France over the past 30 years. It is estimated that the current TCDD body 
burden of citizens in these countries is approximately two parts per trillion-lipid adjusted (ppt), 
down from an estimated 20 ppt in the early 1970s [64].  In contrast, emission of TCDD and other 
AhR agonists is not declining in many developing nations, as a consequence of incomplete burning 
of trash, burning of electronic waste and indoor cooking habits; thus, the body burdens in less 
developed countries can be significantly higher than those noted above [65, 66]. Importantly, 
normal weather patterns can carry airborne contaminants far from their site of origin [67], reducing 
the ability of any one nation to eliminate these toxicants completely from their environment. 
)XUWKHUPRUH QXPHURXV ('&V KDYH EHHQ LGHQWLILHG DV KDYLQJ ³QRQPRQRWRQLF GRVH UHVSRQVH
FXUYHV´ ZKLFK VLPSO\ PHDQV WKDW ORZ GRVH HIIHFWV cannot be predicted by extrapolating from 
effects observed at a high dose.   Many EDCs, including TCDD, not only negatively impact human 
and animal systems at high doses, but also can have equally damaging, albeit different, effects at 
low doses.  Thus, a WR[LFDQWGHPRQVWUDWHGWREH³VDIH´DWDKLJKFRQFHQWUDWLRQFDQQRWEHDVVXPHG
to be equally safe at all lower doses (comprehensively reviewed by [68]). For this reason, an 
unintentional ³KXPDQ H[SHULPHQW´PD\ EH XQGHUZD\ DV LQGXVWULDOL]HG FRXQWULHV PDNH VLJQLILFDQW
strides in reducing emission of toxicants, leading to a decline in the human body burden. 
 
     
2.2. Human Exposure and Reproductive Consequences in Women 
In 1976, a chemical plant explosion near Seveso, Italy led to the highest known exposure of 
residential populations to TCDD [69], and since that time, women living near the site have been 
carefully monitored with regard to reproductive tract disease and pregnancy outcomes. To date, 
these studies have revealed a modest increased risk of endometriosis, a non-significant increased 
risk of sPTB and an increase in time to pregnancy  among the most heavily exposed individuals 
compared to unexposed women [70-74].  More recently, several studies have linked environmental 
exposures not associated with industrial accidents, such as airborne particulate matter, to reduced 
fertility and sPTB in women [75-77].  For example, a recent epidemiology study of women living 
within 4 kilometers of a municipal solid waste incinerator in Italy identified a significant increased 
risk for sPTB [78].  As noted previously, cigarette smoke is replete with a wide array of toxicants, 
including TCDD [79], and has long been associated with reduced fertility and low birthweight due to 
either primary or secondary exposures [80-82].   
 
2.3. Human Exposure and Reproductive Consequences in Men 
Although the primary focus of the current review is EDC exposure and development of 
endometriosis and related reproductive disorders in women, it should be noted that the male 
population is not immune to reproductive consequences of toxicant exposure.  For example, 
following the explosion in Seveso Italy described above (section 2.2), Mocarelli and colleagues 
examined sperm quality and hormone concentrations in men whose mothers were living in the 
exposure area compared to sons of unexposed women born in the same time frame.  Their studies 
revealed reduced sperm count and reduced motility in adult sons, leading the authors to conclude 
that in utero/lactational exposure of males to TCDD can permanently reduce semen quality [83].  
Indeed, a recent report from the European Union examining sperm counts in healthy young men 
reveals a significant decline in human populations over the recent past [84].  Equally concerning, 
the rates of testicular cancer and prostate cancer are on the rise in industrialized nations, 
potentially implicating environmental exposures in their development (reviewed by [85]).  
 
2.3. Human Exposures Associated with Military Action 
In addition to the consequences of industrialization, human toxicant exposures have long 
been associated with military service. During the American war in Vietnam, thousands of pounds of 
the highly toxic herbicide and defoliant known as Agent Orange were sprayed over large areas of 
central and South Vietnam. Agent Orange, a 50:50 mixture of 2,4,5-Trichlorophenoxyacetic acid 
(2,4,5-T) and 2,4-Dichlorophenoxyacetic acid (2,4-D), was manufactured by the Monsanto 
Company DQG'RZ&KHPLFDOIRUXVHLQ³2SHUDWLRQ5DQFK+DQG´+RZHYHUDVDFRQVHTXHQFHRI
contamination during the manufacturing process, TCDD was also unintentionally present in Agent 
Orange.  Over a 10 year period (1961-1971), the U.S. military sprayed the dense jungles of 
Vietnam with Agent Orange, destroying the ground cover it provided to enemy troops [86].  
Unfortunately, agriculture crops and many inhabited villages were also sprayed, resulting in the 
unintentional exposure of South Vietnamese residents, many of whom continue to experience 
significant body burdens and a wide range of health issues, including high rates of early pregnancy 
loss, sPTB, congenital birth defects and serious health problems, including cancer, in surviving 
children [62, 87-90].  After a study in 1970 found that 2,4,5-T could cause birth defects in 
laboratory animals, its use in Vietnam was discontinued and the herbicide was soon banned 
altogether.  
The tragic legacy of Agent Orange is not limited to the Vietnamese population.  It is 
estimated that up to 1.5 million American servicemen were also exposed to TCDD as a 
consequence of Operation Ranch Hand. Some of these veterans reported skin rashes (chloracne), 
cancer, psychological symptoms, birth defects in their children, and other health problems [91]. In 
an effort to determine a potential relationship between the TCDD present in Agent Orange and the 
reported health problems among Veterans, a series of scientific studies was conducted.  These 
studies implicated TCDD in many, (though not all) adverse disease outcomes and eventually led to 
a successful class action lawsuit against Monsanto and Dow Chemical [92]. While it might be easy 
to dismiss Agent Orange exposures as an unfortunate consequence of the unique, forested 
landscape of Vietnam, Veterans of World War II and current servicemen (and women) have also 
been affected by exposure to TCDD and other EDCs over the course of their service.  Specifically, 
the crematoriums associated with the Nazi regime in Germany would have produced substantial 
amounts of dioxin and dioxin-like PCBs [93] H[SRVLQJ ERWK WKH ³UHVLGHQWV´ RI WKH FRQFHQWUDWLRQ
camps as well as local civilians and PLOLWDU\SHUVRQQHO LQ WKHVXUURXQGLQJDUHD 7RGD\¶VPLOLWDU\
personnel serving in Afghanistan and Iraq are also exposed to EDCs via the burn pits used to 
destroy military refuse as well as from the oil fires accidentally or intentionally set [94-97].  Thus, 
exposure to dioxins and other EDCs continues to be an unintentional, additional threat to the 
health of our military personnel and local populations within war zones. The potential, long-term 
reproductive consequences of such exposures have yet to be determined to any of these affected 
individuals and populations. 
Although the environmental exposures detailed in this section centered on examples of 
³KLJKGRVH´H[SRVXUHVWKHUHFDQEHOLWWOHGRXEWWKDWchronic low dose exposures must also occur at 
sites distal to the primary event (via weather patterns, contamination of food and water etc).  Acute, 
high dose effects of TCDD exposure in humans are well-documented (chloroacne, pregnancy loss 
and teratogenic effects), but the consequences of variable, low dose exposures are still being 
determined.  Furthermore, although the potential consequence of developmental exposures are 
difficult to identify in humans, mounting experimental evidence indicates that TCDD and other 
EDCs may have transgenerational effects on not only adult reproductive function but child health 
as well.  
3. Transgenerational Reproductive Dysfunction in a Mouse Model 
 
The overwhelming evidence from numerous epidemiology studies, several of which are 
discussed above (section 2), implicates a likely role for environmental EDC exposure and adverse 
reproductive consequences in humans.  However, carefully controlled, mechanistic studies cannot 
be prospectively conducted in humans; thus we have utilized an animal model known to be 
sensitive to TCDD.  For our studies, pregnant 10-12 wk old female C57BL/6 mice (F0, or founding 
generation) were exposed to TCDD (ȝJNJ) by gavage on embryonic day 15.5 (E15.5), resulting 
in in utero and lactational exposure of offspring.  As illustrated in Figure 1, mice which are exposed 
to TCDD during pregnancy are designated F0, or founding generation.  The feti present with the 
uteri are directly exposed and identified as the F1 generation. Germ cells residing in the F1 feti, 
which have the potential to become the F2 generation, are also directly exposed.  Within this 
rodent model, adult female F1 mice were examined in initial studies for endometrial progesterone 
responsiveness, fertility and pregnancy outcomes, measurements related to the consequence of 
endometriosis in women.  Additional studies conducted in F2-F4 mice examined these same 
endpoints, in order to determine the potential for multi- and transgenerational effects of TCDD 
exposure in females.  As detailed below, we not only identified the occurrence of an endometriosis-
like reproductive phenotype among F1-F4 female mice, many of these animals also exhibited 
histological and functional evidence of co-morbidities which are common in women diagnosed with 
endometriosis .  
3.1. The Endometriosis-related Phenotype in Female Mice 
Using our developmental toxicant exposure model (Figure 1), we initially reported that early 
life/in utero exposure of female mice to TCDD leads to an adult uterine phenotype in animals which 
mimics the reduced uterine progesterone responsiveness observed in women with endometriosis 
[22].  More specifically, we found that F1 females exhibit reduced uterine PR and progesterone-
sensitive TGF- , proteins essential for establishment and maintenance of pregnancy. 
Thus, we were not surprised to find that subfertility was also common among F1 females mated to 
control breeder males.  Approximately 50% of female F1 mice failed to exhibit signs of pregnancy 
(weight gain/nipple prominence) despite multiple matings (4+) and observation of vaginal plugs. In 
addition to subfertility, among females which achieved pregnancy, a high rate of sPTB was 
observed, representing a unique experimental model system to explore this condition [10, 98].  An 
equally important finding was that F2-F4 female mice continued to exhibit endometriosis-like 
histological and functional phenotypes in the absence of additional toxicant exposure. Specifically,  
following a single developmental exposure to TCDD, we identified both multi-generational (F1-F2) 
and transgenerational (F3-F4) occurrence of reproductive disorders that are similar to those 
encountered by endometriosis patients. As outlined in Table 1, our murine studies support a 
potential role for a developmental origin of endometriosis; a disease which currently remains one of 
WKHPRVWSRRUO\XQGHUVWRRGFRQGLWLRQVDIIHFWLQJQRWRQO\ZRPHQ¶VUHSURGXFWLYHSRWHQWLDOEXWWKHLU
overall quality of life.  Addressing the potential medical consequences of an inherited risk of 
developing endometriosis due to an ancestral toxicant exposure will likely challenge our current 
clinical practices related to the management of this disease.  
 
3.2. Adenomyosis 
Adenomyosis, the presence of endometrial glands and stroma embedded within the uterine 
muscle, is frequently identified in women undergoing hysterectomy as a surgical treatment for 
endometriosis [99].  Adenomyosis, like endometriosis, has been associated with reduced fertility, 
pelvic pain, heavy menstrual bleeding and dysmenorrhea [4, 100].   The causes of adenomyosis 
are currently unknown, although both human and animal studies have suggested a role of 
inflammatory processes in the development of this disease [101-104].  In our murine model, we 
recently reported the transgenerational occurrence of adenomyosis in mice exhibiting the 
endometriosis-like uterine phenotype as a consequence of developmental TCDD exposure of F1 
animals [101]. Within this recent study, we conducted a retrospective analysis of uteri from TCDD 
exposed F1 female mice and two generations of their offspring to determine whether histological 
evidence of adenomyosis was present.  Although none of the control mice examined exhibited 
adenomyotic lesions, we identified deep, adenomyotic lesions in the majority of mice with a history 
of direct (F1-F2) or indirect (F3) TCDD exposure.  Specifically, 0/10 controls had adenomyosis 
while 70% (N=10) of F1 animals exhibited deep adenomyosis.  The incidence of advanced disease 
was slightly lower in F2 mice (63%; N=11) and F3 animals (56%; N=9) (Table 1).  Interestingly, 
although current clinical perspectives on adenomyosis in women is primarily focused on identifying 
endometrial invasion into the muscle [105], our murine model clearly demonstrated the presence of 
myometrial cell nests embedded within the endometrium.  As shown in Figure 2, staining for 
smooth muscle actin revealed the presence of individual muscle cells within the endometrial 
stroma in both human and murine samples exhibiting deep adenomyosis suggesting that the 
myometrial compartment may participate in the pathogenesis of this disease. While the initiating 
events leading to the initial development of adenomyosis are not currently known, the occurrence 
of this disease as a co-morbidity in women endometriosis, fibroids and menorrhagia, supports a 
potential role of inflammation in the pathogenesis of this disease as well.  Finally, the 
transgenerational presence of adenomyosis in our murine model of developmental TCDD 
exposure in a single generation provides evidence that epigenetic alterations affecting steroid 
sensitive immune-endocrine crosstalk within the uterus may underlie the development of this, and 
perhaps other, reproductive disorders. 
 
3.3. Heightened Sensitivity to Inflammation following TCDD Exposure 
We have documented a heightened sensitivity to a secondary pro-inflammatory signal both 
within our murine model of developmental TCDD exposure [106]  and following acute in vitro 
exposure to TCDD using human endometrial cells. Specifically, following a 6-10 day exposure 
peroid to TCDD, the anti-inflammatory effects of progesterone are lost in isolated endometrial 
stromal cells acquired from control tissue donors with a concomitant increased reactivity to pro-
inflammatory signals [16, 19].  The potential in vivo significance of altered immune-endocrine 
crosstalk to reproductive success emerged when we observed a doubling of the sPTB rate in 
TCDD exposed F1 and F3 mice in response to an unexpected parvovirus (MPV) outbreak in our 
colony. Importantly, pregnant, unexposed control mice within the same colony, which was housed 
LQ 9DQGHUELOW 8QLYHUVLW\¶V JHQHUDO use, non-barrier facility, were not affected [10].  This 
serendipitous finding further suggested to us that the TCDD mediated decrease in the anti-
inflammatory action of progesterone may have less of a negative impact on the length of 
pregnancy in the absence of an additional pro-inflammatory stressor.  In order to experimentally 
confirm the ³dual-hit´ etiology for increased sPTB in our model, we established a new colony of 
animals within Vanderbilt¶V Specific Pathogen Free Barrier Mouse Facility, which is known to be 
free of MPV and other common mouse pathogens.  Following establishment of this colony, we 
identified the lowest dose of LPS (lipopolysaccharide; 200 ug/kg), which did not independently 
cause PTB in control C57bl/6 mice within our colony.  Mice were subjected to intraperitoneal 
injection of 200 um/kg LPS on E15.5 of pregnancy.  Although control mice were not affected, PTB 
was observed within 24 hrs in 100% of C57bl/6 female mice with a history of direct (F1) or 
ancestral (F3) exposure to TCDD (Table 2).  Interestingly, we noted that the sPTB rate in TCDD 
exposed F1/F3 mice was slightly (but not significantly) lower in the Barrier facility, suggesting that 
mouse pathogens that are commonly present within a general use facility may have also 
contributed to sPTB in mice with a history of early life toxicant exposure.   
While a similar prospective, in vivo human TCDD exposure study would not be possible, our 
murine data suggests that early life TCDD exposure may significantly alter the negative impact of 
either viral or bacterial infection on adult reproductive success. Our murine studies also support our 
previous in vitro observations using isolated human endometrial stromal cells treated with estrogen 
and progesterone to induce decidualization as occurs in vivo in preparation for pregnancy. Using 
this in vitro model, we have documented the effects of TCDD exposure alone and in combination 
with LPS.  Using quantitative RT-PCR, we found that TCDD exposure alone only minimally 
affected PR mRNA expression levels during in vitro decidualizaion, however; the combination of 
LPS and TCDD exposure markedly reduced PR expression [16].  Since disrupting progesterone 
action will induce pregnancy termination in mice or women, the ability of LPS to accelerate the 
negative impact of TCDD on PR expression levels likely explains the enhanced incident of PTB we 
observe within our mouse colony in response to infective agents.  Furthermore, our observations 
utilizing isolated human cells in vitro suggest that women may be equally sensitive to a secondary 
inflammatory event following a developmental or adult exposure to an environmental endocrine 
disruptor. Developing a better understanding of the role that systemic inflammation plays on the 
development of diseases that negatively affect the function of the adult reproductive system would 
potentially allow the use of preventative therapies. In order to understand the marked increase in 
sensitivity of toxicant exposed mice to a secondary inflammatory challenge related to an infection, 
examined the omentum within the peritoneal cavity of our mice with and without a history of 
toxicant exposure. The omentum is a fatty tissue that connects the spleen, stomach, pancreas and 
colon [107].  In both humans and mice, the omentum contains clusters of leukocytesWHUPHG³PLON\
VSRWV´ [108, 109], leading some to suggest that this tissue acts as an immune cell reservoir for the 
movement of cells in and out of the peritoneal cavity.  For example, chronic inflammation 
associated with obesity and diseases such as HIV are known to increase the size and immune cell 
content of the omentum [110, 111].  Compared to disease-free women, Williams et al [112] 
observed alterations in omental proteinase expression of women with endometriosis, which 
correlated with increased body burden of several EDCs (although TCDD was not examined).   As 
shown in Figure 3, compared to control animals, F1 and F3 mice exhibit a marked accumulation of 
immune cells within the omentum, supporting our hypothesis that these animals have a heightened 
³EDVHOLQH´LQIODPPDWRU\SKHQRW\SH 
While it is well established that immune and endocrine dysregulation play a role in 
endometriosis, the mechanisms potentially linking the pathogenesis of endometriosis to 
adenomyosis or other related inflammatory co-morbidities have not been elucidated.  However, our 
murine model and in vitro human cell models suggest that environmental toxicants like TCDD may 
contribute to the etiology of multiple diseases by disrupting normal endocrine-immune cell crosstalk 
both locally and systemically.  Supporting our early life exposure model, other investigators have 
shown that adult exposure of mice to TCDD led to a rapid, systemic increase in leukocyte markers, 
chemokines and macrophage infiltration, promoting a chronic inflammatory state [113, 114]. 
Endometriosis is currently being viewed by many investigators as a chronic, systemic inflammatory 
disease that is characterized not only by the presence of enhanced numbers of activated, 
peritoneal immune cells but also by the negative impact of activated immune cells to overall 
reproductive success [115, 116]. However, at this juncture, whether altered systemic inflammation 
is the result or a driver for reproductive tract disease pathogenesis is not currently known. In an 
elegant review, Kobayashi et al [116] hypothesized that endometriosis may be a consequence of 
immune cell response to an infection in conjunction with oxidative stress associated with 
menstruation, resulting in a chronic, sterile inflammation which ultimately promotes disease.  Our 
murine studies support this theory, but also extend it as our studies suggest that an early life 
exposure to an EDC such as TCDD may mimic an infection; thereby leading to chronic 
inflammation and an increased risk of disease development.   
 
3.4. Adhesive Disease 
Patients with endometriosis frequently undergo surgery to remove ectopic disease or for 
hysterectomy in an attempt to prevent disease recurrence [1].  Unfortunately, compared to the 
general population, these women are at a higher risk of not only surgery-associated adhesions, but 
also for the development of spontaneous adhesive disease [117]. The basic pathophysiology of 
postsurgical adhesion development is known to involve inflammatory processes that occur during 
normal wound healing. Certainly, macrophages and neutrophils play key roles in the initiation of 
inflammation related to wound healing, by releasing both inflammatory cytokines and 
proangiogenic factors. Women with endometriosis are known to exhibit dysregulated immune cell 
function, which likely contributes to the increased risk of developing adhesive disease [115]. In an 
effort to explore the pathogenesis of these co-morbidities, we examined the development of 
spontaneous adhesive disease in a chimeric mouse model of human experimental endometriosis 
[118, 119].  For this model, we mimicked retrograde menstruation by injecting human endometrial 
tissue fragments intraperitoneally into ovariectomized, immunocompromised nude mice treated 
with estradiol. As reported in these published studies, we noted a cooperative effect of the 
presence of endometrial tissue fragments on the development of post-surgical adhesions when 
tissue fragments were introduced into the peritoneum within 16 hours of ovariectomy.   Sham 
surgery (removal of the fat pad surrounding ovary, but not the ovary) or tissue injection in the 
absence of experimental endometriosis was not associated with increased adhesive disease [118, 
119].  Thus, within the peritoneal cavity, immune cell responses to injury, similar to infection or 
radiation therapy, may promote formation of adhesions [120].  
Additionally, over the course of our studies utilizing TCDD exposed mice, we noted that 
while adhesions were rarely observed in control mice at necropsy, adhesive disease was common 
among F1-F3 mice.  As described above in section 3.3, immune cell numbers and LPS 
responsiveness was enhanced in mice with a history of TCDD exposure, suggesting that toxicant 
exposed mice may exhibit an increased risk for development of post-surgical adhesions due to 
their altered peritoneal phenotype. In order to examine the risk of adhesive disease in TCDD-
exposed mice, we established a syngeneic endometriosis model in control and F1 mice within 16 
hours of a surgical ovariectomy similar to the approach with the chimeric adhesion model 
described earlier in this section [118, 119].  As shown in Table 3 and Figure 4, injection of uterine 
fragments into the peritoneal cavity of TCDD-exposed F1 mice within 16 hours of peritoneal 
surgery led to the development of both multiple adhesions and ectopic sites of endometrial growth. 
Interestingly, injection of uterine tissue fragments derived from either toxicant-exposed F1 mice or 
control animals led to a similar degree of adhesion development within the peritoneal cavity of F1 
recipient animals (Table 3).  Notably, control recipients exhibited minimal lesions or adhesions, 
regardless of whether the donor tissue was obtained from a control or F1 animal.  These data 
suggest that the inflammatory peritoneal environment may be more relevant to the risk of post-
surgical adhesive disease than that of the uterine phenotype.  In future experiments it will be 
necessary to examine whether there is a transgenerational risk for developing adhesive following 
early life TCDD exposure as we noted in our endometriosis and adhesive disease models.  
 
 
4. TCDD-Mediated Epigenetic Events  
As we discussed in a previous review [101], reduced fertility and an increased risk of sPTB 
in female mice across multiple generations following a single, developmental exposure to TCDD 
strongly suggests toxicant mediated epigenetic modifications have occurred. Epigenetic marking of 
DNA is now recognized as an important mechanism by which gene expression can be altered 
without a change to the DNA sequence.  The primary role of epigenetic modification is to control 
DNA accessibility, i.e. the ability of the cellular machinery to act as a control switch for gene 
expression by activating or inhibiting transcription. The best described mechanisms of epigenetic 
changes are methylation and acetylation of DNA and histones [121]. Hypermethylation of DNA is 
generally associated with gene silencing while hyperacetylation of histones leads to chromatin 
relaxation and unwinding which promotes gene transcription. Appropriate patterns of methylation 
and acetylation are necessary for normal expression and regulation of certain genes.  Thus, in 
DGGLWLRQ WR LQIRUPDWLRQ SUHVHQW ZLWKLQ DQ LQGLYLGXDO¶V VSHFLILF JHQHWLF FRGH '1$ VHTXHQFH 
epigenetic alterations can modulate how this otherwise hard-wired genetic information is utilized 
within a cell.  Significantly, although such epigenetic changes are stable, they are themselves 
subject to modification [122].  For example, while lifestyle choices such as smoking can promote 
epigenetic changes which can accelerate aging, it is theoretically possible that epigenetic therapies 
can reverse these changes in order to combat certain cancers and other diseases [123-125].  
Additionally, epigenetic marks occurring within the germline are inheritable [126, 127] and can 
positively or negatively affect offspring.  For this reason, lifestyle choices that preserve a healthy 
epigenome may dramatically reduce not only individual¶VULVNRI disease, but may promote the long 
term health of future offspring. 
 
4.1. Studies linking abnormal epigenetic marks to endometriosis in women.   
Numerous studies have reported alterations in epigenetic marks of multiple endometrial 
genes from samples obtained from women with endometriosis compared to disease-free control 
subjects (for example, [128-130]).  Perhaps predictably, studies have also identified differential 
methylation/acetylation profiles between the eutopic endometrium and ectopic sites of tissue 
growth in women with endometriosis (for example, [131-133]).  Several functional studies linked 
altered decidualization capacity in women with endometriosis to abnormal epigenetic marks (ie, 
[134, 135]).  For example, subjecting primary cultures of stromal cells, obtained from women with 
or without endometriosis, to a standard decidualization protocol, Bulun and colleagues identified a 
failure of decidualization-associated downregulation of DNMT3B hormones [136].  These 
investigators concluded that endometriosis ³may contribute to an aberrant epigenetic fingerprint 
that misdirects gene expression and contributes to its altered response to steroidV´[136].   In our 
laboratory, using methylation-specific PCR, we identified hypermethylation of the PR gene in 
endometrial tissues obtained from women with endometriosis compared to disease-free women 
(Figure 5A).  Significantly, whereas isolated endometrial stromal cells obtained from women 
without endometriosis do not exhibit methylation of the PR gene, short-term treatment of these 
cells with interleukin 1 (IL-1), an inflammatory cytokine produced by both immune and endometrial 
cells is associated with hypermethylation (Figure 5B).  Further implicating inflammatory processes 
in development of the endometriosis phenotype, Wu et al [137] demonstrated that treatment of 
isolated, control human endometrial epithelial cells with TNF-ĮOHGWRK\SHUPHWK\ODWLRQRI WKH PR 
promoter and a loss of PR-B protein expression.  Using the human endometriotic epithelial cell line 
12Z and stromal cell line 22B, the Arosh laboratory revealed that selective inhibition of 
prostaglandin E2 (PGE2) receptors EP2 and EP4 modulates DNA methylation and histone 
modification machinery proteins, suggesting these receptors may be useful for therapeutic targets.  
However, findings between the numerous studies investigating the potential relevance of 
epigenetic alterations and disease development are not always in agreement. For example, both 
hypomethylation of HOXA10 [128] and hypermethylation of HOXA10 [131] have been described in 
women with endometriosis compared to controls.  Although differences in patient selection, 
variation among control populations and sample size likely contribute to the inconsistencies among 
various studies, Saare et al, [138] recently described a variation in cycle-dependent methylation 
patterns in healthy women compared to endometriosis patients.  These investigators found only 
minimal differences between endometriosis patients and controls, while differences between cycle 
phases, in particular, between the late secretory phase and menstruation, were more robust.  
Therefore, future studies attempting to assess epigenetic differences between healthy women and 
those with endometriosis will need to carefully consider the cycle phase during which the tissues 
are obtained as an additional variable. 
 
4.2. Studies linking TCDD-mediated epigenetic events to reproductive disease in mice 
We have previously demonstrated that in vitro TCDD exposure of human endometrial cells 
suppresses expression of both PR-B mRNA and protein, which may be mediated by the local 
action of toxicant-induced inflammatory cytokines [15, 19].  As described above (section 3.3), F1-
F3 mice within our developmental TCDD exposure study were found to exhibit both reduced PR 
protein expression within the uterus and a heightened peritoneal inflammatory response. These 
data, taken together with the in vitro human cell data, suggested to us that the loss of progesterone 
sensitivity associated with developmental exposure of mice to TCDD may be due to an epigenetic 
modification, mediated by inflammatory processes. Therefore, we recently examined the 
methylation status of the PR gene in uterine samples from our female mice.   As discussed earlier, 
DNA hypermethylation can mediate gene silencing and is an important mechanism by which 
heritable epigenetic modifications may occur [139].  As we previously reported, examination of 
murine uteri by methylation-specific PCR (MS-PCR) revealed partial methylation of the PR in 60% 
of tissues removed from F1 females (exposed to TCDD in utero) while this gene was largely 
unmethylated in similar tissue samples acquired from control mice [102].  In order to determine if 
PR gene hypermethylation is a transient or stable (heritable) effect, we similarly examined uterine 
tissues removed from F3 females, revealing partial methylation of the PR in 40% of these animals 
[102].  These data, presented in Table 1, suggest that the transgenerational infertility phenotype 
and associated risk of sPTB in these animals may be due to epigenetic silencing of PR as a 
consequence of ancestral TCDD exposure.  Although mice utilized for methylation analysis were 
not mated, it is interesting to note that the frequency of hypermethylation observed in these mice 
strongly correlated with the frequency of infertility among previously examined F1 and F3 mice 
(Table 1).  
 
 
5. Developing a New Human Model for Reproductive Toxicology  
Despite the fidelity of our developmental TCDD exposure model to endometrial disease and 
dysfunction associated with endometriosis in women, these animals do not menstruate and thus do 
not spontaneously develop ectopic disease. Additionally, despite the universal necessity of 
progesterone in mammalian pregnancy, the role and expression patterns of specific progesterone 
receptors vary across species [140].  Furthermore, differences between the murine and human 
inflammatory responses [141, 142] may complicate human translation of TCDD toxicity studies 
conducted in mice. Thus, it is critically important to validate the murine results using models which 
better recapitulate the in vivo human condition, in order to accurately define the impact and 
mechanisms of action of environmental toxicants such as TCDD.  
Clearly, intentional exposure of reproductive age women to TCDD or other EDCs is neither 
ethical nor feasible.  Therefore, our traditional in vitro studies utilized human endometrial stromal 
and epithelial cells maintained in static culture models for analysis of cellular responses to acute 
TCDD. As noted above (section 3.3), these in vitro studies revealed that this toxicant acts to 
disrupt the anti-inflammatory action of progesterone, leading to an increase in endometrial cell 
sensitivity to inflammatory stimuli [16]. Nevertheless, mechanistic interpretation of these results 
remains limited as a consequence of a non-physiological experimental setting [143-145]. Multi-cell 
culture assays, including organ cultures, co-cultures and tissue recombinants, clearly demonstrate 
the significant role of cell-cell communication in normal endometrial physiology [15, 146, 147].  
Furthermore, using co-cultures of murine stromal and epithelial cells, Buchanan et al [148] 
UHYHDOHG WKDW7&''¶VQHJDWLYHHIIHFWRn the epithelium is largely mediated by the stromal cells. 
Together, these findings demonstrate the significant contribution of the cellular microenvironment 
to normal organ function and underscore the need to incorporate multiple cells into studies 
attempting to understand the mechanism of action of EDCs. Because the in vivo physiological 
function of the endometrium is maintained by spatial and temporal cues mediated though complex 
endocrine, paracrine and immune components, it becomes critical to mimic these facets in a more 
robust in vitro model.  
Technical challenges constrain the utility of static cell culture models to identify how TCDD 
disrupts cell-cell communication and immune-endocrine regulation, ultimately leading to 
reproductive dysfunction. However, recent advances in microfabrication technologies have enabled 
researchers to mimic the physiological microenvironment of human tissues. These tissue 
HQJLQHHUHG GHYLFHV RU ³2UJDQV-on-&KLSV´ 2R& RIIHU WKH DELOLW\ WR SHUIRUP PXOWL-cellular co-
cultures in a microfluidic system to mimic the physiological nature of the tissue and examine the 
crosstalk between cells and distal organs [149] 6HYHUDO IXQGLQJ DJHQFLHV LQFOXGLQJ WKH 1,+¶V
National Center for Advancing Translational Sciences (NCATS) and the Environmental Protection 
Agency understand this issue and have prioritized initiatives for the development of 3D devices 
capable of mimicking the structure and function of human organs. Long term culture stability, 
appropriate high resolution microscopy techniques, use of microporous biomaterials, cell 
compartmentalization and continuous perfusion and sampling allow for qualitative and quantitative 
analysis of real time interactions between cells [150, 151]. Individualized perfusion of cells 
additionally allows for introduction of immune cells or test agent (ie, therapy or EDC). Significantly, 
OoC can be interconnected, allowing organ to organ communication.  For example, placing the 
³OLYHU-on-FKLS´ [152] upstream of the endometrium on a chip would potentiate the ability to 
physiologically address how EDCs, xenobiotics and their metabolites impact human endometrial 
homeostasis.  
With regard to the reproductive tract, several groups are pursuing the use of microfluidic 
OoC devices as both research tools and for assisted reproductive technology applications [153, 
154]. Using these techniques, our group is also currently developing an Organ-on-Chip microfluidic 
model of both the eutopic and ectopic human endometrium to further advance our understanding 
of the mechanisms by which TCDD leads to endometrial dysregulation and disease (Figure 6).  
The ability to interconnect the OoC devices will dramatically enhance our ability to examine the 
downstream consequences of ectopic disease on the eutopic endometrium. These models will also 
serve as a platform to test and screen therapeutic agents in order to identify high efficacy 
candidates prior to testing in animal models. Although the OoC models are still at the prototype 
phase, we expect that in the near future, these models will be routinely utilized for pathological, 
toxicological and biological studies and will significantly transform our in vitro modeling capabilities.    
 
Summary/Conclusions 
The emerging evidence that many diseases and conditions affecting adults are influenced 
by the prevailing in utero environment during development [20] suggests that reproductive health 
may also be negatively influenced by disruption of normal fetal development.  Within this review, 
we have discussed our findings in a murine model that demonstrates an epigenetic link between 
early life exposure to TCDD and the development of reduced progesterone sensitivity within the 
adult reproductive tract across multiple generations. Using both in vivo and in vitro models, we 
have shown that the loss of endometrial progesterone sensitivity, a well-recognized component of 
endometriosis, is biologically linked to an inflammatory-like pattern of cell-cell communication 
within the uterus [6-8].  Whether reduced reproductive tract responsiveness to progesterone leads 
to the development of endometriosis or emerges as a consequence of the inflammatory nature of 
the disease is currently unknown. Nevertheless, once in place, a loss in the differentiation 
promoting, anti-inflammatory action of progesterone would be expected to not only compromise 
reproductive success [10], but potentially promote the development of common comorbidities (ie, 
adenomyosis, adhesive disease).   
 
6. Methodology 
 
6.1 In utero TCDD Exposure:  
 Virgin female and male C57bl/6 mice were purchased from Harlan Sprague-Dawley 
,QGLDQDSROLV ,1 DQG KRXVHG LQ 9DQGHUELOW 8QLYHUVLW\ 0HGLFDO &HQWHU¶V $QLPDO &DUH )DFLOLW\
according to National Institutes of Health and institutional guidelines for laboratory animals. All 
animals received food and water ad libitum.  Animal rooms were maintained at a temperature of 
22-Û& DQG D UHODWLYH KXPLGLW\ RI -50% on a 12-h light:dark schedule.  Experiments 
described herein were approved by Vanderbilt University Institutional Animal Care and Use 
Committee in accordance with the Animal Welfare Act.  
C57bl/6 females (N=20), aged 10-12 weeks, were mated with intact males of similar age.  
Upon observation of a vaginal plug, females were separated and denoted as day 0.5 of 
SUHJQDQF\(3UHJQDQWPLFH)ZHUHH[SRVHGWR7&''ȝJNJLQFRUQRLORUYHKLFOH
alone by gavage at 1100 hours CST on E15.5 (when organogenesis is complete).  This in utero 
plus lactational exposure paradigm results in direct exposure of the feti (F1 mice) as well as 
direct exposure of the fetal germ cells, which have the potential to become the F2 generation.  
This dose of TCDD reflects the more rapid clearance of this toxicant in mice compared to 
humans and is well below the LD50 for adult mice of this strain (230µg/kg) [155].   TCDD given 
at this time and dose is not overtly teratogenic and gestation length was not affected in the F0 
animals; pups (F1 mice) were typically born on E20.   
 
6.2 Generation of F2/F3 females   
A single control, proven breeder male was placed with a single F1 female and monitored for 
the presence of a vaginal plug (E0.5) each morning.  Following the identification of a plug, the 
male was removed.  Females were weighed prior to mating and again on E16.5, when they 
were examined for signs of pregnancy (weight gain, nipple prominence).  An animal was 
considered infertile after 4 positive vaginal plugs with no subsequent pregnancy.  Second 
generation (F2) animals were weaned at 4 weeks of age at which time male pups were 
removed.  At 10-12 weeks, F2 females were mated to control males of similar age and 
monitored as above.  Note:  As previously described, like their siblings, F1 and F2 males exhibit 
subfertility [10, 156].  Perhaps as a consequence of reduced fertility in directly exposed 
animals, to date, mating of non-sibling F1 male and female mice or non-sibling F2 male and 
female mice has not resulted in offspring [102]; thus, toxicant exposed mice are necessarily 
mated to control partners. 
 
6.3 Euthanasia:   
Adult mice were euthanized between 6 and 7 months of age by cervical dislocation after 
anesthetic overdose (isoflurane).  Animals were typically euthanized during the estrus phase as 
indicated by vaginal smear.   
 6.4 Immunohistochemistry/Histochemistry:   
Hematoxylin and eosin staining was performed on formalin-fixed, paraffin-embeded tissues 
by standard methods.  Immunohistochemical staining of murine tissues for smooth muscle actin 
(SMA) was performed after heat activated antigen retrieval using anti-SMA (Cat.#RB-9010-P1, 
Thermo) for one hour at a 1:500 dilution:  The Bond Polymer Refine detection system was used 
for visualization. Slides were then dehydrated, cleared and coverslipped for morphological 
analysis.  Histopathological assessments were performed using an Olympus BX51 microscope 
system and images captured using an Olympus DP71 digital camera. 
 
6.5 Syngeneic Experimental Endometriosis in Mice: 
Experimental endometriosis was established in control and F1 female mice by 
intraperitoneal injection of minced uterine tissues from donor mice (control or F1). All donor 
mice were in estrus at the time of euthanasia and collection of tissues, while recipient mice 
were ovariectomized and provided a slow release capsule containing estrdaiol 16 hrs prior to 
tissue injection.  Recipient mice were euthanized 5 days after injection of syngeneic tissues and 
examined for adhesive disease and experimental endometriosis.  Adhesion/lesion scores were 
determined by standard methodology as previously described [119]. 
 
6.6 Methylation-Specific PCR 
Endometrial biopsies were obtained from women with endometriosis after providing written, 
informed consent.  DNA was extracted from whole tissue samples or from isolated endometrial 
stromal cells as previously described [15].  Using non-quantitative, methylation-specific PCR, 
bisulfite-modified DNA was assessed for PR-B methylation status using primers specific for 
methylated and unmethylated DNA.  Experiments utilizing human tissues and described herein 
were reviewed and approved by 9DQGHUELOW¶V,QVWLWXWLRQDO5HYLHZ%RDUG 
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Figure Legends: 
 
Figure 1: Developmental TCDD Exposure Model. Pregnant C57BL/6 mice (F0 generation) are 
H[SRVHGWRDVLQJOHDFXWH7&''GRVHȝJNJE\JDYDJHRQHPEU\RQLFGD\(ZKHQ
organogenesis is complete. However, at the time of exposure, fetal germ cells are present within 
the F1 feti gonads.  Since these cells have the potential to become the F2 generation, TCDD 
treatment of a pregnant dam (F0) ultimately results in direct exposure of three generations (F0-F2).   
 
Figure 2:  Smooth Muscle Actin Stain of Human and Murine Uteri.  We recently assessed the 
presence of adenomyosis, nests of endometrial glands and stromal within the muscle, in archived 
samples of human and murine uteri [101].  Using smooth muscle actin (SMA) 
immunohistochemistry, which localizes to both myometrial cells and muscle cells surrounding 
some vessels, we frequently identified muscles cells within the endometrial layer of women with 
endometriosis and within tissues obtained from mice with a history of direct (F1-F2) or ancestral 
(F3) TCDD exposure. Representative images from this recent study are presented herein. (A) SMA 
staining in uterine tissue from a woman with surgically confirmed endometriosis.  Muscle cells 
ZLWKLQWKHHQGRPHWULDOOD\HUDUHGHQRWHGE\DQDUURZ$QDGHQRP\RWLFOHVLRQGHQRWHG³D´LVDOVR
visible within this image. (B) SMA staining of uterine tissue from an F3 mouse reveals a large gland 
within the endometrial layer that is surrounded by a layer of muscle cells. In both images, muscle 
cells appear brown and vessels are marked by an arrowhead.    Original magnification 400x. 
 
Figure 3:  Hematoxylin and Eosin staining of Murine Omentum.  Immune cells present within 
the omentum are readily apparent due to uptake of hematoxylin (dark blue).  Immune cells are 
rarely observed in the omentum of control mice (A), while large numbers of immune cells are 
visible in both F1 (B) and F3 (C) omentum.  Original magnification, 100x; Inset, 200x. 
 
Figure 4:  Gross Morphology of Adhesive Disease.  Experimental endometriosis was 
established in control (A) and F1 (B) mice by intraperitoneal injection of minced uterine tissues 
from donor mice with the same phenotype as the recipient. Recipient mice were euthanized 5 days 
after injection of syngeneic tissues and examined for adhesive disease.  As shown in (A), 
adhesions developing in control mice were typically thin and fragile (arrows), with single point 
attachment sites.  In contrast, adhesions developing in toxicant exposed mice were frequently 
dense, with multiple attachment sites (B). 
 
Figure 5:  Hypermethylation of the Endometrial Progesterone Receptor Gene in Women with 
Endometriosis 
DNA was extracted by standard methodology from whole endometrial tissues obtained during the 
proliferative phase from women with and without endometriosis (A) and from endometrial stromal 
cells isolated from proliferative phase biopsies obtained from disease-free donors (B).  Using non-
quantitative, methylation-specific PCR, bisulfite-modified DNA was assessed for PR-B methylation 
status.  As shown in Panel A, the endometrial PR-B gene from women without endometriosis is 
completely unmodified, while tissues from women with endometriosis exhibit partial methylation.  
Partial methylation of PR-B was induced in healthy stromal cells following 48 hr treatment with IL-1 
%1IRUDOOJURXSV U=unmethylated; M=methylated, WT:  whole tissue (untreated). 
 Figure 6:  Schematic of a MicrofluidLF ³2UJDQ-on-&KLS´ 0RGHO RI WKH (QGRPHWULXP
(EndoChip). The endometrial microenvironment plays a critical role in both the homeostasis of 
tissue function and etiology of diseases. To recreate the organ architecture on a chip, the major 
cellular components of the endometrium (i.e. the immune, vascular, stromal and epithelial 
components) are isolated and then reassemble in microfluidic devices fabricated with 
biocompatible materials (i.e. polydimethylsiloxane, PDMS) and hydrogels.  These devices 1) 
reduce the need for large cell numbers, 2) individually compartmentalize each cell type within 
independent chambers, 3) maintain short and long term growth and 4) are sensitive enough for 
biochemical and imaging analysis. Perfusion of immune cells, with control over temporal endocrine 
signaling and physiological mechanical stimuli (e.g. shear stresses), further enhances the 
physiological performance of in vitro cell culture.  
 
 
 
  
References:  
1. Bulun, S.E., Endometriosis. N Engl J Med, 2009. 360(3): p. 268-79. 
2. Brosens, I., et al., Risks of adverse pregnancy outcome in endometriosis. Fertil Steril, 2012. 
98(1): p. 30-5. 
3. Sinaii, N., et al., High rates of autoimmune and endocrine disorders, fibromyalgia, chronic 
fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. 
Hum Reprod, 2002. 17(10): p. 2715-24. 
4. Struble, J., S. Reid, and M.A. Bedaiwy, Adenomyosis: A Clinical Review of a Challenging 
Gynecologic Condition. J Minim Invasive Gynecol, 2016. 23(2): p. 164-85. 
5. Tirlapur, S.A., et al., The 'evil twin syndrome' in chronic pelvic pain: a systematic review of 
prevalence studies of bladder pain syndrome and endometriosis. Int J Surg, 2013. 11(3): p. 233-
7. 
6. Bruner-Tran, K.L., et al., Medical management of endometriosis: emerging evidence linking 
inflammation to disease pathophysiology. Minerva Ginecol, 2013. 65(2): p. 199-213. 
7. Kiyomizu, M., et al., Association of two polymorphisms in the peroxisome proliferator-activated 
receptor-gamma gene with adenomyosis, endometriosis, and leiomyomata in Japanese women. 
J Soc Gynecol Investig, 2006. 13(5): p. 372-7. 
8. Guo, S.W., The association of endometriosis risk and genetic polymorphisms involving dioxin 
detoxification enzymes: a systematic review. Eur J Obstet Gynecol Reprod Biol, 2006. 124(2): 
p. 134-43. 
9. Rier, S.E., et al., Endometriosis in rhesus monkeys (Macaca mulatta) following chronic 
exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol, 1993. 21(4): p. 433-41. 
10. Bruner-Tran, K.L. and K.G. Osteen, Developmental exposure to TCDD reduces fertility and 
negatively affects pregnancy outcomes across multiple generations. Reprod Toxicol, 2011. 
31(3): p. 344-50. 
11. Bruner-Tran, K.L., et al., The potential role of environmental toxins in the pathophysiology of 
endometriosis. Gynecol Obstet Invest, 1999. 48 Suppl 1: p. 45-56. 
12. Cummings, A.M., J.L. Metcalf, and L. Birnbaum, Promotion of endometriosis by 2,3,7,8-
tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. 
Toxicol Appl Pharmacol, 1996. 138(1): p. 131-9. 
13. Yang, J.Z., S.K. Agarwal, and W.G. Foster, Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-
p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicol 
Sci, 2000. 56(2): p. 374-81. 
14. Yang, J.Z. and W.G. Foster, Continuous exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits 
the growth of surgically induced endometriosis in the ovariectomized mouse treated with high 
dose estradiol. Toxicol Ind Health, 1997. 13(1): p. 15-25. 
15. Igarashi, T.M., et al., Reduced expression of progesterone receptor-B in the endometrium of 
women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-
tetrachlorodibenzo-p-dioxin. Fertil Steril, 2005. 84(1): p. 67-74. 
16. Resuehr, D., et al., Progesterone-dependent regulation of endometrial cannabinoid receptor 
type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal 
cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Fertil Steril, 2012. 98(4): p. 948-56 
e1. 
17. Bruner-Tran, K.L. and K.G. Osteen, Dioxin-like PCBs and endometriosis. Syst Biol Reprod Med, 
2010. 56(2): p. 132-46. 
18. Porpora, M.G., et al., Role of environmental organochlorinated pollutants in the development of 
endometriosis. Clin Exp Obstet Gynecol, 2013. 40(4): p. 565-7. 
19. Bruner-Tran, K.L., et al., Dioxin may promote inflammation-related development of 
endometriosis. Fertil Steril, 2008. 89(5 Suppl): p. 1287-98. 
20. Heindel, J.J., Role of exposure to environmental chemicals in the developmental basis of 
reproductive disease and dysfunction. Semin Reprod Med, 2006. 24(3): p. 168-77. 
21. Chen, C.Y., et al., Disposition of polychlorinated dibenzo-p-dioxins, dibenzofurans, and non-
ortho polychlorinated biphenyls in pregnant long evans rats and the transfer to offspring. Toxicol 
Appl Pharmacol, 2001. 173(2): p. 65-88. 
22. Nayyar, T., et al., Developmental exposure of mice to TCDD elicits a similar uterine phenotype 
in adult animals as observed in women with endometriosis. Reprod Toxicol, 2007. 23(3): p. 326-
36. 
23. Anway, M.D., et al., Epigenetic transgenerational actions of endocrine disruptors and male 
fertility. Science, 2005. 308(5727): p. 1466-9. 
24. Manikkam, M., et al., Transgenerational actions of environmental compounds on reproductive 
disease and identification of epigenetic biomarkers of ancestral exposures. PLoS One, 2012. 
7(2): p. e31901. 
25. Newbold, R.R., Developmental exposure to endocrine-disrupting chemicals programs for 
reproductive tract alterations and obesity later in life. Am J Clin Nutr, 2011. 94(6 Suppl): p. 
1939S-1942S. 
26. Taylor, H.S., Endocrine disruptors affect developmental programming of HOX gene expression. 
Fertil Steril, 2008. 89(2 Suppl): p. e57-8. 
27. Anway, M.D. and M.K. Skinner, Epigenetic programming of the germ line: effects of endocrine 
disruptors on the development of transgenerational disease. Reprod Biomed Online, 2008. 
16(1): p. 23-5. 
28. Eichenlaub-Ritter, U. and F. Pacchierotti, Bisphenol A Effects on Mammalian Oogenesis and 
Epigenetic Integrity of Oocytes: A Case Study Exploring Risks of Endocrine Disrupting 
Chemicals. Biomed Res Int, 2015. 2015: p. 698795. 
29. Xin, F., M. Susiarjo, and M.S. Bartolomei, Multigenerational and transgenerational effects of 
endocrine disrupting chemicals: A role for altered epigenetic regulation? Semin Cell Dev Biol, 
2015. 43: p. 66-75. 
30. Melnick, R., et al., Summary of the National Toxicology Program's report of the endocrine 
disruptors low-dose peer review. Environ Health Perspect, 2002. 110(4): p. 427-31. 
31. Diamanti-Kandarakis, E., et al., Endocrine-disrupting chemicals: an Endocrine Society scientific 
statement. Endocr Rev, 2009. 30(4): p. 293-342. 
32. Gluckman, P.D., et al., Losing the war against obesity: the need for a developmental 
perspective. Sci Transl Med, 2011. 3(93): p. 93cm19. 
33. Hanson, M.A., F.M. Low, and P.D. Gluckman, Epigenetic epidemiology: the rebirth of soft 
inheritance. Ann Nutr Metab, 2011. 58 Suppl 2: p. 8-15. 
34. Sweeney, M.F., et al., Environmental endocrine disruptors: Effects on the human male 
reproductive system. Rev Endocr Metab Disord, 2016. 
35. Bofinger, D.P., et al., Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant 
cultures of human endometrium. Toxicol Sci, 2001. 62(2): p. 299-314. 
36. Nayyar, T., K.L. Bruner-Tran, and K. Osteen, Developmental Dioxin and Endometriosis, in 
Reproductive and Developmental Toxicology, R. Gupta, Editor. 2011, Academic Press/Elsevier: 
USA. 
37. Peters, J.M., et al., Amelioration of TCDD-induced teratogenesis in aryl hydrocarbon receptor 
(AhR)-null mice. Toxicol Sci, 1999. 47(1): p. 86-92. 
38. Nguyen, L.P. and C.A. Bradfield, The search for endogenous activators of the aryl hydrocarbon 
receptor. Chem Res Toxicol, 2008. 21(1): p. 102-16. 
39. Adachi, J., et al., Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in 
human urine. J Biol Chem, 2001. 276(34): p. 31475-8. 
40. Denison, M.S. and S.R. Nagy, Activation of the aryl hydrocarbon receptor by structurally diverse 
exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol, 2003. 43: p. 309-34. 
41. Seidel, S.D., et al., Activation of the Ah receptor signaling pathway by prostaglandins. J 
Biochem Mol Toxicol, 2001. 15(4): p. 187-96. 
42. Sinal, C.J. and J.R. Bend, Aryl hydrocarbon receptor-dependent induction of cyp1a1 by bilirubin 
in mouse hepatoma hepa 1c1c7 cells. Mol Pharmacol, 1997. 52(4): p. 590-9. 
43. Andrieux, L., et al., Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by 
the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol Pharmacol, 2004. 
65(4): p. 934-43. 
44. Revel, A., et al., Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects sperm 
from DNA damage and apoptosis caused by benzo(a)pyrene. Reprod Toxicol, 2001. 15(5): p. 
479-86. 
45. Takamura, T., et al., Activation of the aryl hydrocarbon receptor pathway may ameliorate 
dextran sodium sulfate-induced colitis in mice. Immunol Cell Biol, 2010. 88(6): p. 685-9. 
46. Birnbaum, L.S., Evidence for the role of the Ah receptor in response to dioxin. Prog Clin Biol 
Res, 1994. 387: p. 139-54. 
47. Buck Louis, G.M., Persistent environmental pollutants and couple fecundity: an overview. 
Reproduction, 2014. 147(4): p. R97-R104. 
48. Ramesh, A., et al., Bioavailability and risk assessment of orally ingested polycyclic aromatic 
hydrocarbons. Int J Toxicol, 2004. 23(5): p. 301-33. 
49. Lee, J., et al., Male and female mice show significant differences in hepatic transcriptomic 
response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. BMC Genomics, 2015. 16: p. 625. 
50. Myllymaki, S.A., et al., In utero and lactational exposure to TCDD; steroidogenic outcomes differ 
in male and female rat pups. Toxicol Sci, 2005. 88(2): p. 534-44. 
51. Naville, D., et al., Low-dose food contaminants trigger sex-specific, hepatic metabolic changes 
in the progeny of obese mice. FASEB J, 2013. 27(9): p. 3860-70. 
52. Sobolewski, M., et al., Sex-specific enhanced behavioral toxicity induced by maternal exposure 
to a mixture of low dose endocrine-disrupting chemicals. Neurotoxicology, 2014. 45: p. 121-30. 
53. Heimler, I., et al., Dioxin perturbs, in a dose- and time-dependent fashion, steroid secretion, and 
induces apoptosis of human luteinized granulosa cells. Endocrinology, 1998. 139(10): p. 4373-
9. 
54. Heimler, I., et al., Modulation of ovarian follicle maturation and effects on apoptotic cell death in 
Holtzman rats exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in utero and lactationally. 
Reprod Toxicol, 1998. 12(1): p. 69-73. 
55. Okino, S.T. and J.P. Whitlock, Jr., The aromatic hydrocarbon receptor, transcription, and 
endocrine aspects of dioxin action. Vitam Horm, 2000. 59: p. 241-64. 
56. Hankinson, O., The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol, 1995. 35: 
p. 307-40. 
57. Olsen, H., E. Enan, and F. Matsumura, Regulation of glucose transport in the NIH 3T3 L1 
preadipocyte cell line by TCDD. Environ Health Perspect, 1994. 102(5): p. 454-8. 
58. Sorg, O., et al., 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: 
identification and measurement of TCDD metabolites. Lancet, 2009. 374(9696): p. 1179-85. 
59. Harrad, S., et al., Human dietary intake and excretion of dioxin-like compounds. J Environ 
Monit, 2003. 5(2): p. 224-8. 
60. Malisch, R. and A. Kotz, Dioxins and PCBs in feed and food--review from European 
perspective. Sci Total Environ, 2014. 491-492: p. 2-10. 
61. Pompa, G., F. Caloni, and M.L. Fracchiolla, Dioxin and PCB contamination of fish and shellfish: 
assessment of human exposure. Review of the international situation. Vet Res Commun, 2003. 
27 Suppl 1: p. 159-67. 
62. Schecter, A., et al., Characterization of dioxin exposure in firefighters, residents, and chemical 
workers in the Irkutsk Region of Russian Siberia. Chemosphere, 2002. 47(2): p. 147-56. 
63. Birnbaum, L.S., Endocrine effects of prenatal exposure to PCBs, dioxins, and other xenobiotics: 
implications for policy and future research. Environ Health Perspect, 1994. 102(8): p. 676-9. 
64. Aylward, L.L. and S.M. Hays, Temporal trends in human TCDD body burden: decreases over 
three decades and implications for exposure levels. J Expo Anal Environ Epidemiol, 2002. 
12(5): p. 319-28. 
65. Archibong, A.E., et al., Endocrine disruptive actions of inhaled benzo(a)pyrene on ovarian 
function and fetal survival in fisher F-344 adult rats. Reprod Toxicol, 2012. 34(4): p. 635-43. 
66. Vanker, A., et al., Home environment and indoor air pollution exposure in an African birth cohort 
study. Sci Total Environ, 2015. 536: p. 362-7. 
67. Ramos, Y., et al., Spatio-temporal models to estimate daily concentrations of fine particulate 
matter in Montreal: Kriging with external drift and inverse distance-weighted approaches. J Expo 
Sci Environ Epidemiol, 2015. 
68. Vandenberg, L.N., et al., Hormones and endocrine-disrupting chemicals: low-dose effects and 
nonmonotonic dose responses. Endocr Rev, 2012. 33(3): p. 378-455. 
69. Homberger, E., et al., The Seveso accident: its nature, extent and consequences. Ann Occup 
Hyg, 1979. 22(4): p. 327-67. 
70. Wesselink, A., et al., Maternal dioxin exposure and pregnancy outcomes over 30 years of 
follow-up in Seveso. Environ Int, 2014. 63: p. 143-8. 
71. Warner, M., et al., Serum dioxin concentrations and quality of ovarian function in women of 
Seveso. Environ Health Perspect, 2007. 115(3): p. 336-40. 
72. Eskenazi, B., et al., Maternal serum dioxin levels and birth outcomes in women of Seveso, Italy. 
Environ Health Perspect, 2003. 111(7): p. 947-53. 
73. Eskenazi, B., et al., Serum dioxin concentrations and endometriosis: a cohort study in Seveso, 
Italy. Environ Health Perspect, 2002. 110(7): p. 629-34. 
74. Bois, F.Y. and B. Eskenazi, Possible risk of endometriosis for Seveso, Italy, residents: an 
assessment of exposure to dioxin. Environ Health Perspect, 1994. 102(5): p. 476-7. 
75. DeFranco, E., et al., Air pollution and stillbirth risk: exposure to airborne particulate matter 
during pregnancy is associated with fetal death. PLoS One, 2015. 10(3): p. e0120594. 
76. DeFranco, E., et al., Exposure to airborne particulate matter during pregnancy is associated 
with preterm birth: a population-based cohort study. Environ Health, 2016. 15(1): p. 6. 
77. Stillerman, K.P., et al., Environmental exposures and adverse pregnancy outcomes: a review of 
the science. Reprod Sci, 2008. 15(7): p. 631-50. 
78. Candela, S., et al., Air pollution from incinerators and reproductive outcomes: a multisite study. 
Epidemiology, 2013. 24(6): p. 863-70. 
79. Wilson, C.L., et al., Assessment of dioxin and dioxin-like compounds in mainstream smoke from 
selected US cigarette brands and reference cigarettes. Food Chem Toxicol, 2008. 46(5): p. 
1721-33. 
80. Camlin, N.J., E.A. McLaughlin, and J.E. Holt, Through the smoke: use of in vivo and in vitro 
cigarette smoking models to elucidate its effect on female fertility. Toxicol Appl Pharmacol, 
2014. 281(3): p. 266-75. 
81. Levy, D., et al., Smoking and adverse maternal and child health outcomes in Brazil. Nicotine 
Tob Res, 2013. 15(11): p. 1797-804. 
82. Stone, W.L., B. Bailey, and N. Khraisha, The pathophysiology of smoking during pregnancy: a 
systems biology approach. Front Biosci (Elite Ed), 2014. 6: p. 318-28. 
83. Mocarelli, P., et al., Perinatal exposure to low doses of dioxin can permanently impair human 
semen quality. Environ Health Perspect, 2011. 119(5): p. 713-8. 
84. Rolland, M., et al., Decline in semen concentration and morphology in a sample of 26,609 men 
close to general population between 1989 and 2005 in France. Hum Reprod, 2013. 28(2): p. 
462-70. 
85. Woodruff, T.J., et al., Proceedings of the Summit on Environmental Challenges to Reproductive 
Health and Fertility: executive summary. Fertil Steril, 2008. 89(2 Suppl): p. e1-e20. 
86. Lewis, J., Smokey Bear in Vietnam. Environmental History, 2006. 11(3): p. 598-603. 
87. Anh, N.T., et al., Maternal risk factors associated with increased dioxin concentrations in breast 
milk in a hot spot of dioxin contamination in Vietnam. J Expo Sci Environ Epidemiol, 2014. 
24(5): p. 489-96. 
88. Nghi, T.N., et al., Dioxins and Nonortho PCBs in Breast Milk of Vietnamese Mothers Living in 
the Largest Hot Spot of Dioxin Contamination. Environ Sci Technol, 2015. 49(9): p. 5732-42. 
89. Schecter, A., et al., A follow-up: high level of dioxin contamination in Vietnamese from agent 
orange, three decades after the end of spraying. J Occup Environ Med, 2002. 44(3): p. 218-20. 
90. Tai, P.T., et al., Dioxin exposure in breast milk and infant neurodevelopment in Vietnam. Occup 
Environ Med, 2013. 70(9): p. 656-62. 
91. Herbicides., I.o.M.U.C.t.R.t.H.E.i.V.V.o.E.t., Veterans and Agent Orange: Health Effects of 
Herbicides Used in Vietnam. 1994, Washington DC: National Academies Press. 
92. Challenges in military health care: perspectives on health status and the provision of care, ed. J. 
Stanley and J.D. Blain. 1993: Transaction Publishers. 
93. Mari, M. and J.L. Domingo, Toxic emissions from crematories: a review. Environ Int, 2010. 
36(1): p. 131-7. 
94. Aurell, J., B.K. Gullett, and D. Yamamoto, Emissions from open burning of simulated military 
waste from forward operating bases. Environ Sci Technol, 2012. 46(20): p. 11004-12. 
95. Doucet, I., Desert Storm syndrome: sick soldiers and dead children? Med War, 1994. 10(3): p. 
183-94. 
96. Emmerova, M. and F. Jirava, Is Gulf War Syndrome really a mystery? Med Confl Surviv, 2004. 
20(3): p. 209-17. 
97. Woodall, B.D., et al., Emissions from small-scale burns of simulated deployed U.S. military 
waste. Environ Sci Technol, 2012. 46(20): p. 10997-1003. 
98. Ding, T., et al., Developmental dioxin exposure of either parent is associated with an increased 
risk of preterm birth in adult mice. Reprod Toxicol, 2011. 31(3): p. 351-8. 
99. Vercellini, P., et al., Adenomyosis: epidemiological factors. Best Pract Res Clin Obstet 
Gynaecol, 2006. 20(4): p. 465-77. 
100. Cockerham, A.Z., Adenomyosis: a challenge in clinical gynecology. J Midwifery Womens 
Health, 2012. 57(3): p. 212-20. 
101. Bruner-Tran KL, et al., Developmental Toxicant Exposure is Associated with Transgenerational 
Adenomyosis in a Murine Model. Biology of Reproduction 2016 (in review). 
102. Bruner-Tran, K.L., et al., The Role of Endocrine Disruptors in the Epigenetics of Reproductive 
Disease and Dysfunction: Potential Relevance to Humans. Curr Obstet Gynecol Rep, 2012. 
1(3): p. 116-123. 
103. Jichan, N., L. Xishi, and S.W. Guo, Promoter hypermethylation of progesterone receptor isoform 
B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a 
demethylation agent. Reprod Sci, 2010. 17(11): p. 995-1005. 
104. Li, Y., et al., Accumulation of nerve growth factor and its receptors in the uterus and dorsal root 
ganglia in a mouse model of adenomyosis. Reprod Biol Endocrinol, 2011. 9: p. 30. 
105. Valentini, A.L., et al., Adenomyosis: from the sign to the diagnosis. Imaging, diagnostic pitfalls 
and differential diagnosis: a pictorial review. Radiol Med, 2011. 116(8): p. 1267-87. 
106. Glore, D.R., et al. DEVELOPMENTAL DIOXIN EXPOSURE PROMOTES A HYPER-
INFLAMMATORY PERITONEAL MICROENVIRONMENT WHICH MAY CONTRIBUTE TO THE 
ENDOMETRIOSIS-LIKE PHENOTYPE. in American Society for Reproductive Medicine. 2012. 
San Diego, CA. 
107. Williams, R. and H. White, The greater omentum: its applicability to cancer surgery and cancer 
therapy. Curr Probl Surg, 1986. 23(11): p. 789-865. 
108. Krist, L.F., et al., Novel isolation and purification method permitting functional cytotoxicity 
studies of macrophages from milky spots in the greater omentum. J Immunol Methods, 1995. 
184(2): p. 253-61. 
109. Krist, L.F., et al., Cellular composition of milky spots in the human greater omentum: an 
immunochemical and ultrastructural study. Anat Rec, 1995. 241(2): p. 163-74. 
110. Westcott, E., et al., Fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid 
cells in patients with and without Crohn's disease and their therapeutic implications. Inflamm 
Bowel Dis, 2005. 11(9): p. 820-7. 
111. Pond, C.M., Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids, 
2005. 73(1): p. 17-30. 
112. Williams, K.E., et al., Urine, peritoneal fluid and omental fat proteomes of reproductive age 
women: Endometriosis-related changes and associations with endocrine disrupting chemicals. J 
Proteomics, 2015. 113: p. 194-205. 
113. Pande, K., S.M. Moran, and C.A. Bradfield, Aspects of dioxin toxicity are mediated by interleukin 
1-like cytokines. Mol Pharmacol, 2005. 67(5): p. 1393-8. 
114. Vogel, C.F., et al., Modulation of the chemokines KC and MCP-1 by 2,3,7,8-tetrachlorodibenzo-
p-dioxin (TCDD) in mice. Arch Biochem Biophys, 2007. 461(2): p. 169-75. 
115. Herington, J.L., et al., Immune interactions in endometriosis. Expert Rev Clin Immunol, 2011. 
7(5): p. 611-26. 
116. Kobayashi, H., et al., Pathogenesis of endometriosis: the role of initial infection and subsequent 
sterile inflammation (Review). Mol Med Rep, 2014. 9(1): p. 9-15. 
117. Fortin, C.N., G.M. Saed, and M.P. Diamond, Predisposing factors to post-operative adhesion 
development. Hum Reprod Update, 2015. 21(4): p. 536-51. 
118. Herington, J.L., et al., Development and prevention of postsurgical adhesions in a chimeric 
mouse model of experimental endometriosis. Fertil Steril, 2011. 95(4): p. 1295-301 e1. 
119. Herington, J.L., et al., Dietary fish oil supplementation inhibits formation of endometriosis-
associated adhesions in a chimeric mouse model. Fertil Steril, 2013. 99(2): p. 543-50. 
120. Imudia, A.N., et al., Pathogenesis of Intra-abdominal and pelvic adhesion development. Semin 
Reprod Med, 2008. 26(4): p. 289-97. 
121. Zoghbi, H.Y. and A.L. Beaudet, Epigenetics and Human Disease. Cold Spring Harb Perspect 
Biol, 2016. 8(2). 
122. Su, X., K.E. Wellen, and J.D. Rabinowitz, Metabolic control of methylation and acetylation. Curr 
Opin Chem Biol, 2016. 30: p. 52-60. 
123. Bai, H., et al., Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical 
implications for molecular targeted therapy. J Cell Mol Med, 2016. 
124. Golabek, K., et al., Potential use of histone deacetylase inhibitors in cancer therapy. Contemp 
Oncol (Pozn), 2016. 19(6): p. 436-40. 
125. Sinha, D., et al., Resveratrol for breast cancer prevention and therapy: Preclinical evidence and 
molecular mechanisms. Semin Cancer Biol, 2016. 
126. Gabory, A., L. Attig, and C. Junien, Epigenetic mechanisms involved in developmental 
nutritional programming. World J Diabetes, 2011. 2(10): p. 164-75. 
127. Morgan, H.D., et al., Epigenetic reprogramming in mammals. Hum Mol Genet, 2005. 14 Spec 
No 1: p. R47-58. 
128. Kim, J.J., et al., Altered expression of HOXA10 in endometriosis: potential role in 
decidualization. Mol Hum Reprod, 2007. 13(5): p. 323-32. 
129. Naqvi, H., et al., Altered genome-wide methylation in endometriosis. Reprod Sci, 2014. 21(10): 
p. 1237-43. 
130. Wu, Y., et al., Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, 
DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril, 2007. 87(1): p. 24-32. 
131. Andersson, K.L., et al., DNA methylation of HOXA10 in eutopic and ectopic endometrium. Hum 
Reprod, 2014. 29(9): p. 1906-11. 
132. Xiaomeng, X., et al., Aberrant histone acetylation and methylation levels in woman with 
endometriosis. Arch Gynecol Obstet, 2013. 287(3): p. 487-94. 
133. Zidan, H.E., et al., COX-2 gene promoter DNA methylation status in eutopic and ectopic 
endometrium of Egyptian women with endometriosis. J Reprod Immunol, 2015. 112: p. 63-7. 
134. Dyson, M.T., et al., Genome-wide DNA methylation analysis predicts an epigenetic switch for 
GATA factor expression in endometriosis. PLoS Genet, 2014. 10(3): p. e1004158. 
135. Kobayashi, H., et al., Understanding the role of epigenomic, genomic and genetic alterations in 
the development of endometriosis (review). Mol Med Rep, 2014. 9(5): p. 1483-505. 
136. Dyson, M.T., et al., Aberrant expression and localization of deoxyribonucleic acid 
methyltransferase 3B in endometriotic stromal cells. Fertil Steril, 2015. 104(4): p. 953-963 e2. 
137. Wu, Y., et al., Promoter hypermethylation of progesterone receptor isoform B (PR-B) in 
endometriosis. Epigenetics, 2006. 1(2): p. 106-11. 
138. Saare, M., et al., The influence of menstrual cycle and endometriosis on endometrial 
methylome. Clin Epigenetics, 2016. 8: p. 2. 
139. Guerrero-Bosagna, C. and M.K. Skinner, Environmentally induced epigenetic transgenerational 
inheritance of phenotype and disease. Mol Cell Endocrinol, 2012. 354(1-2): p. 3-8. 
140. Malassine, A., J.L. Frendo, and D. Evain-Brion, A comparison of placental development and 
endocrine functions between the human and mouse model. Hum Reprod Update, 2003. 9(6): p. 
531-9. 
141. Seok, J., et al., Genomic responses in mouse models poorly mimic human inflammatory 
diseases. Proc Natl Acad Sci U S A, 2013. 110(9): p. 3507-12. 
142. Takao, K. and T. Miyakawa, Genomic responses in mouse models greatly mimic human 
inflammatory diseases. Proc Natl Acad Sci U S A, 2015. 112(4): p. 1167-72. 
143. Eddie, S.L., et al., Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp 
Biol Med (Maywood), 2014. 239(9): p. 1192-202. 
144. Young, E.W. and D.J. Beebe, Fundamentals of microfluidic cell culture in controlled 
microenvironments. Chem Soc Rev, 2010. 39(3): p. 1036-48. 
145. Wikswo, J.P., et al., Scaling and systems biology for integrating multiple organs-on-a-chip. Lab 
Chip, 2013. 13(18): p. 3496-511. 
146. Bruner, K.L., et al., Transforming growth factor beta mediates the progesterone suppression of 
an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad 
Sci U S A, 1995. 92(16): p. 7362-6. 
147. Cunha, G.R., P.S. Cooke, and T. Kurita, Role of stromal-epithelial interactions in hormonal 
responses. Arch Histol Cytol, 2004. 67(5): p. 417-34. 
148. Buchanan, D.L., et al., Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse 
uterus: critical role of the aryl hydrocarbon receptor in stromal tissue. Toxicol Sci, 2000. 57(2): p. 
302-11. 
149. Hutson, M.S., et al., Organs-on-Chips as Bridges for Predictive Toxicology. Applied In Vitro 
Toxicology, submitted. 
150. Esch, M.B., T.L. King, and M.L. Shuler, The role of body-on-a-chip devices in drug and toxicity 
studies. Annu Rev Biomed Eng, 2011. 13: p. 55-72. 
151. Lantada, A.D., P.L. Morgado, and P.O. García, Micro-manufacturing Technologies for 
Biodevices: Interacting at a Cellular Scale, in Handbook on Advanced Design and 
Manufacturing Technologies for Biomedical Devices, , A.D. Lantada, Editor. 2013, Springer 
Science & Business Media. p. 225-245. 
152. Bale, S.S., et al., In vitro platforms for evaluating liver toxicity. Exp Biol Med (Maywood), 2014. 
239(9): p. 1180-91. 
153. Smith, G.D., S. Takayama, and J.E. Swain, Rethinking in vitro embryo culture: new 
developments in culture platforms and potential to improve assisted reproductive technologies. 
Biol Reprod, 2012. 86(3): p. 62. 
154. Swain, J.E., et al., Thinking big by thinking small: application of microfluidic technology to 
improve ART. Lab Chip, 2013. 13(7): p. 1213-24. 
155. Vogel, C., et al., Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune 
system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and 
CYP1A2 related enzyme activities. Arch Toxicol, 1997. 71(6): p. 372-82. 
156. Bruner-Tran, K.L., et al., Developmental exposure of mice to dioxin promotes transgenerational 
testicular inflammation and an increased risk of preterm birth in unexposed mating partners. 
PLoS One, 2014. 9(8): p. e105084. 
 
 
 Table 1:  Cumulative Overview of Reproductive Characteristics in Control and Toxicant Exposed 
Female Mice
1 
1
Data compiled from references 10, 101 and 102. 
2
Delivery was considered term when occurring E19-E21 (plug date is considered E0.5). 
3
Whole uteri collected from non-pregnant mice at estrus. 
Mouse History Pregnancy Rate Term Delivery
2 
Adenomyosis Methylation of PR
3 
Control 95-100% 100% 0% 0% 
F1 46 37 70 66 
F3 50 60 56 33 
Tables
 Table 2:  Incidence of preterm birth by animal care facility and in response to a secondary 
inflammatory challenge 
 
1
The Non-Barrier Facility is a general use mouse housing area that may contain common mouse pathogens. 
2
The Barrier facility is a Specific Pathogen Free mouse housing facility that is known to be free of specific mouse 
pathogens, including MPV. 
Mouse History Non-Barrier Facility
1
 Non-Barrier  
+MPV 
Barrier Facility
2
 Barrier +                
Low dose LPS 
Control 0 0 0 0 
F1 36 63 28 100 
F3 25 40 20 100 
Tables
  
Table 3:  Endometriosis-Associated Adhesive Disease 
Recipient/Donor    N % with 
Adhesions 
Adhesion 
Score 
p* %with 
lesions 
Lesion 
score 
p* 
Control/Control 10 30 0.4  80 1.3  
F1/Control 3 33 0.7 NS 33 0.33 NS 
Control/F1  3 100 2.4 0.03 66 1.7 NS 
F1/F1 7 100 2.9 <0.002 86 2.6 <0.005 
*compared to Control mice receiving Control tissue. 
NS:  Not-significant 
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germ cells) 
Figure
Figure
Click here to download high resolution image
Figure 3
Click here to download high resolution image
Figure 4
Click here to download high resolution image
Figure 5
Click here to download high resolution image
*Conflict of Interest Statement
Click here to download Conflict of Interest Statement: COI.pdf
